Tulane University

Futó vizsgálatok

• Még nem toboroz

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· 4. fázis· Forrás

• Toboroz

  Combatting HIV Or Other STIs Early (CHOOSE)

  NCT07510048· Forrás

• Toboroz

  Detection of Atrial Fibrillation Using PPG From Smartphone Cameras

  NCT07779213· Forrás

• Toboroz

  A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  NCT07463183· 2. fázis· Forrás

• Toboroz

  Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  NCT07296484· 2. fázis· Forrás

• Toboroz

  Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

  NCT07143669· Forrás

• Toboroz

  Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  NCT06837181· Forrás

• Toboroz

  Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  NCT06750731· Forrás

• Toboroz

  Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

  NCT04703166· Forrás

• Meghívásos bevonás

  Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

  NCT06868459· Forrás

• Toboroz

  A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

  NCT06822738· 3. fázis· Forrás

• Fut, nem toboroz

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· 3. fázis· Forrás

• Fut, nem toboroz

  A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

  NCT06713239· Forrás

• Fut, nem toboroz

  Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

  NCT06632327· 3. fázis· Forrás

• Toboroz

  Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

  NCT06472206· Forrás

• Toboroz

  A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  NCT06504589· Forrás

• Fut, nem toboroz

  A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  NCT06095128· 4. fázis· Forrás

• Fut, nem toboroz

  A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  NCT06045754· 4. fázis· Forrás

• Toboroz

  Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

  NCT06133322· Forrás

• Fut, nem toboroz

  Lupus Education Alliance Program

  NCT05243875· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

  NCT06052059· 3. fázis· Forrás

• Fut, nem toboroz

  Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

  NCT06065098· Forrás

• Fut, nem toboroz

  Real World Registry for Use of the Ion Endoluminal System

  NCT06004440· Forrás

• Fut, nem toboroz

  Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

  NCT05639556· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Forrás

• Toboroz

  Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

  NCT05723653· Forrás

• Fut, nem toboroz

  Emicizumab in Patients With Acquired Hemophilia A

  NCT05345197· 2. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

  NCT05500222· 3. fázis· Forrás

• Fut, nem toboroz

  Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

  NCT05382208· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

  NCT05308654· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

  NCT05353257· 3. fázis· Forrás

• Fut, nem toboroz

  Prospective Study of Pregnancy in Women With Cystic Fibrosis

  NCT04828382· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· 3. fázis· Forrás

• Toboroz

  Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  NCT04269902· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

  NCT04586231· 3. fázis· Forrás

• Fut, nem toboroz

  Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

  NCT04513717· 3. fázis· Forrás

• Fut, nem toboroz

  The Allergen Reduction and Child Health Study (ARCHS)

  NCT04331353· Forrás

• Fut, nem toboroz

  Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

  NCT04071223· 2. fázis· Forrás

• Fut, nem toboroz

  NCI COVID-19 in Cancer Patients, NCCAPS Study

  NCT04387656· Forrás

• Fut, nem toboroz

  Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

  NCT04134260· 3. fázis· Forrás

• Fut, nem toboroz

  Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  NCT04228978· Forrás

• Fut, nem toboroz

  Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

  NCT03976843· 2. fázis· Forrás

• Fut, nem toboroz

  Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

  NCT04797403· Forrás

• Fut, nem toboroz

  Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

  NCT03932201· Forrás

• Toboroz

  Stroke Thrombectomy and Aneurysm Registry

  NCT04994756· Forrás

• Toboroz

  Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  NCT03937635· 3. fázis· Forrás

• Fut, nem toboroz

  S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

  NCT04071457· 3. fázis· Forrás

• Fut, nem toboroz

  Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

  NCT03924895· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma

  NCT03933735· 1/2. fázis· Forrás

• Fut, nem toboroz

  Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

  NCT03793166· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• HIV-fertőzés3 toboroz
• Cisztás fibrózis2 toboroz
• Colitis ulcerosa2 toboroz
• Pitvarfibrilláció2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Crohn-betegség1 toboroz
• Csontritkulás1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Magas vérnyomás1 toboroz
• Mielóma multiplex1 toboroz
• Stroke (szélütés)1 toboroz
• Zöldhályog (glaukóma)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· 3. fázis· Forrás

• Lezárult

  A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

  NCT06016088· 1/2. fázis· Forrás

• Lezárult

  Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

  NCT06124131· Forrás

• Lezárult

  Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

  NCT05671835· 2. fázis· Forrás

• Lezárult

  Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

  NCT05199337· 1/2. fázis· Forrás

• Lezárult

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Forrás

• Lezárult

  A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

  NCT05014412· 2. fázis· Forrás

• Lezárult

  Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

  NCT04091386· Forrás

• Leállították

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· 3. fázis· Forrás

• Leállították

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· 3. fázis· Forrás

• Lezárult

  Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

  NCT04300920· 3. fázis· Forrás

• Lezárult

  Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

  NCT04396860· 2/3. fázis· Forrás

• Leállították

  Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

  NCT03926624· 3. fázis· Forrás

• Lezárult

  CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

  NCT03934840· 2. fázis· Forrás

• Lezárult

  Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

  NCT03891446· 3. fázis· Forrás

• Lezárult

  Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

  NCT03850782· 3. fázis· Forrás

• Lezárult

  Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

  NCT03529045· Forrás

• Lezárult

  An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

  NCT03338790· 2. fázis· Forrás

• Lezárult

  Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

  NCT03205696· Forrás

• Lezárult

  Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer

  NCT03098836· 2. fázis· Forrás

• Leállították

  Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

  NCT03307980· 2. fázis· Forrás

• Lezárult

  A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

  NCT02815891· Forrás

• Lezárult

  Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

  NCT02635009· 2/3. fázis· Forrás

• Lezárult

  Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

  NCT01553149· 2. fázis· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

  NCT02883049· 3. fázis· Forrás

• Lezárult

  Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

  NCT01503632· 3. fázis· Forrás

• Lezárult

  Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

  NCT01371981· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

  NCT01231906· 3. fázis· Forrás

• Lezárult

  Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

  NCT01190930· 3. fázis· Forrás

• Lezárult

  Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

  NCT01096368· 3. fázis· Forrás

• Lezárult

  Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

  NCT01013649· 3. fázis· Forrás

• Lezárult

  Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

  NCT00980460· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

  NCT00945009· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

  NCT00653068· 3. fázis· Forrás

• Lezárult

  Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

  NCT00601900· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

  NCT00557193· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

  NCT00336024· 3. fázis· Forrás

• Lezárult

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

  NCT00379340· 3. fázis· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

  NCT00408005· 3. fázis· Forrás

• Lezárult

  Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

  NCT00352534· 3. fázis· Forrás

• Lezárult

  Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease

  NCT00107198· 2. fázis· Forrás

• Toboroz

  Pompe Disease Registry Protocol

  NCT00231400· Forrás

• Lezárult

  Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

  NCT00085735· 3. fázis· Forrás

• Toboroz

  Fabry Disease Registry & Pregnancy Sub-registry

  NCT00196742· Forrás

• Toboroz

  International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

  NCT00358943· Forrás

Vizsgálati helyszínek

• Tulane University1 vizsgálat
• Duplicate_Tulane University /ID# 2403271 vizsgálat
• Tulane University45 vizsgálat
• Tulane University School of Medicine61 vizsgálat
• Tulane University School of Medicine-Gastroenterology and Hepatology (Site 0154)1 vizsgálat
• Tulane University School of Medicine-Gastroenterology and Hepatology (Site 1073)1 vizsgálat
• Tulane University School of Medicine /ID# 2376321 vizsgálat
• Tulane University School of Medicine /ID# 2423221 vizsgálat
• Tulane University School of Medicine /ID# 2448541 vizsgálat
• Tulane University School of Medicine /ID# 2512040 vizsgálat
• Tulane University School of Medicine /ID# 2774861 vizsgálat
• Tulane University School of Medicine (Site 0088)1 vizsgálat
• Tulane University School of Medicine (Site 0098)1 vizsgálat
• Tulane University School of Medicine- Site Number : 8400013 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• HIV-fertőzés129 munka · 5 vizsgálat
• Pitvarfibrilláció73 munka · 3 vizsgálat
• Idiopátiás tüdőfibrózis11 munka · 3 vizsgálat
• Hemofília9 munka · 4 vizsgálat
• Magas vérnyomás4 munka · 6 vizsgálat
• ANCA-asszociált vasculitis3 munka · 0 vizsgálat